Approval · Notice of Compliance 19087 · 2017
ZANTAC: Notice of Compliance 19087
Issued March 21, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19087
- Date
- March 21, 2017
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANTAC | 02230287 | Cancelled Post Market |
| ZANTAC MAXIMUM STRENGTH NON-PRESCRIPTION | 02277301 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB
- RANITIDINE HCL 150 MG per TAB